Discontinuation

 

HPS Pharmacies wish to advise that Mundipharma Australia has given notice of the discontinuation of:

Dilaudid®– HP 50mg/5mL Ampoules
Hydromorphone hydrochloride
ARTG 67358

Dilaudid®-HP 50mg/5mL will no longer be available from mid-2017 due to a change in manufacturer. This product will be permanently replaced with a more concentrated formulation containing hydromorphone 50mg/mL. The new formulation will be available from 1st August 2017.

Dilaudid®-HP 50mg/mL concentrated solution for injection must be diluted before administration. Appropriate sterile diluents include 0.9% sodium chloride, 5% dextrose, and water for injections. The following table highlights some of the other differences between these products. This should be reviewed in conjunction with the product information and formulation advice.

Current Formulation

New Formulation

Strength

50mg/5mL

50mg/1mL

ARTG

67358

272634

Ampoule

5mL amber glass ampoule

1mL colourless glass ampoule

Ampoule label

50mg/5mL solution for injection 5mL

50mg in 1mL concentrated solution for IM, IV or SC injection

Carton label

Solution for injection 50mg/5mL

Concentrated solution for injection 50mg in 1mL

Presentation

5 x 5mL ampoules

5 X 1mL ampoules

PBS status

Subsidised

Private prescription

 

Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your facility and clinicians if there is an immediate impact to your facility.

Please retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies or Mundipharma Australia on 1800 188 009.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates